Cathy Pedevillano, LMHC, MA, MS Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 5 Adams St Apt B, Lake Pleasant, MA 01347 Phone: 978-855-0688 |
News Archive
More seizures, more stress and appointments being cancelled are among the challenges faced by young people with epilepsy during the pandemic, the charity Young Epilepsy has found.
New research from the University of Michigan Life Sciences Institute has determined how a common holiday spice-cinnamon-might be enlisted in the fight against obesity.
A team of Beaumont Health researchers from Radiology, Radiation Oncology and Urology studied the relationship between benign prostatic hyperplasia, or BPH, and prostate cancer in 405 men by quantitatively looking at different parts of prostate tissue on MRI.
Neurologix, Inc. today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for intellectual property central to the company's approach to the treatment of epilepsy. The patent allowance specifically refers to Neurologix's patent application, "Methods and Compositions for the Treatment of Neurological Disease," which covers the treatment of seizures associated with temporal lobe epilepsy by direct administration into the brain's temporal lobe of an AAV vector encoding Neuropeptide Y (NPY).
Last year, a Wyss Institute team of scientists described the development of a new device to treat sepsis that works by mimicking our spleen. It cleanses pathogens and toxins from blood circulating through a dialysis-like circuit. Now, the Wyss Institute team has developed an improved device that synergizes with conventional antibiotic therapies and that has been streamlined to better position it for near-term translation to the clinic.
› Verified 9 days ago